ArticleSAGE open medical case reports2024
A rare clinical presentation of pedunculated superficial angiomyxoma in the anal canal: A case report.
Article in SAGE open medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superficial angiomyxoma is an infrequent benign soft tissue tumor, clinically presented as slow-growing, painless cutaneous, or subcutaneous mass. It is mostly described in middle aged population with preference location in trunk, head, neck, and genitalia. Herein, we report a rare growth variant of a solitary superficial angiomyxoma with uncommon site of occurrence in a 39-year-old female. Pedunculated superficial angiomyxoma originating in anal canal is extremely rare. Histological features of the lesion comprising of spindle-shaped and stellate cells dispersed in myxoid stroma and prominent thin-walled blood vessels defined the diagnosis of superficial angiomyxoma. Tumor cells with immunohistochemistry analysis showed positivity for vimentin and CD34 and negativity for S100, while Ki-67 showed a low proliferation index. The recurrence of superficial angiomyxoma is previously described, but in our case no signs of recurrence were seen in follow-up for a period of 6 months. Superficial angiomyxoma should be considered as differential diagnosis with other polypoid or nodular masses in anal canal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.